Clinical AI company Sensyne Health has signed a new Strategic Research Agreement (SRA) with US-based healthcare provider Sentara Healthcare. Under the deal, Sensyne will have access to de-identified patient data covering Sentara’s 3.6 million patients and the two companies will collaborate on new clinical algorithms to support patients with chronic kidney disease and congestive heart failure….